A Win For Myovant Sciences Ltd.
Mon, Jun 01, 2020 at 05:34 PM
Myovant Sciences Ltd. (MYOV:NYSE) shot up at $16.93, a gain of 38.2%. On Fri 29 May 20, MYOV:NYSE touched a New 2-Week Intraday Low of $11.89. The stock appeared on our News Catalysts scanner on Mon 01 Jun 20 at 09:28 AM in the 'BIOTECH' category. From Fri 15 May 20, the stock recorded 44.44% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Myovant Sciences Ltd. (MYOV:NYSE)
Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.
Top 10 Gainers:
- Cemtrex, Inc. (CETX:NASDAQ), 172.44%
- Digital Ally, Inc. (DGLY:NASDAQ), 75.89%
- Allied Esports Entertainment Inc. (AESE:NASDAQ), 61.63%
- Amyris, Inc. (AMRS:NASDAQ), 43.43%
- Intec Pharma Ltd. (NTEC:NASDAQ), 42.86%
- Myovant Sciences Ltd. (MYOV:NYSE), 38.2%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 33.07%
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 31.55%
- CIRCOR International, Inc. (CIR:NYSE), 30.16%
- Inspired Entertainment, Inc. (INSE:NASDAQ), 29.74%